臨床症状
Marion Ferrandez Y Montesinos1, Christelle Filleau2, Valeria Manera3
1University of Côte d'Azur, laboratory LAPCOS and laboratory CoBTeK, Nice, Alpes Maritimes, France.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
まとめ
本研究では、軽度神経認知障害を有する高齢者のレジリエンスを高めるための混合介入を調査する。このプログラムは、認知行動療法、ポジティブ心理学、マインドフルネス瞑想を組み合わせて、より良い加齢アウトカムを目指す。
科学分野:
- 老年医学および認知神経学; 心理学および行動医学
- Gerontology and Cognitive Neurology; Psychology and Behavioral Medicine
背景:
- レジリエンスは、加齢を成功させるために不可欠であり、認知機能低下を防ぎ、幸福感を高める。; 高齢者のレジリエンスを育成することは非常に重要であるが、神経認知障害を有する者のレジリエンスを改善するためのエビデンスは限られている。
- Resilience is crucial for successful aging, protecting against cognitive decline and enhancing well-being.; Fostering resilience is vital for older adults, yet evidence for improving it in those with neurocognitive disorders is limited.
研究 の 目的:
- 軽度神経認知障害を有する60歳以上の個人におけるレジリエンスを高める混合介入の効果を評価する。; 認知行動療法、ポジティブ心理学、ヨガニドラ(マインドフルネス瞑想)を組み合わせた3ヶ月プログラムをテストする。
- To evaluate a mixed intervention's effectiveness in enhancing resilience among individuals over 60 with mild neurocognitive disorders.; To test a 3-month program combining cognitive-behavioral therapy, positive psychology, and Yoga Nidra (mindfulness meditation).
主な方法:
- 90人の参加者を3つのグループに無作為に割り付けた:対照群、活動的対照群(認知刺激)、介入群(レジリエンスプログラム)。; 介入群は3ヶ月間、週1.5時間のセッションに参加する。対照群は週1回の電話連絡を受ける。; 介入前、介入後、および1ヶ月後と3ヶ月後のフォローアップで評価を実施する。
- 90 participants randomized into three groups: control, active control (cognitive stimulation), and intervention (resilience program).; Intervention groups attend weekly 1.5-hour sessions for 3 months; control group receives weekly calls.; Assessments conducted pre-intervention, post-intervention, and at 1 and 3 months follow-up.
主要な成果:
- 研究開始は2月中旬、介入完了は5月末。; 初回フォローアップ評価は6月末に予定されており、予備的な結果が得られる。; 次回の会議で発表するために、包括的な結果が期待される。
- Study commencement in mid-February, with intervention completion by end of May.; First follow-up assessments scheduled for end of June, providing preliminary results.; Anticipation of comprehensive results for presentation at an upcoming conference.
結論:
- 発見は加齢に対するアプローチを再構築し、高齢者が繁栄することを可能にする可能性がある。; この研究は、軽度神経認知障害を有する高齢者のためのレジリエンスを高めるプログラムを開発するためのフレームワークを提供することを目的としている。
- Findings could reshape approaches to aging, enabling older adults to thrive.; This research aims to provide a framework for developing resilience-enhancing programs for older adults with mild neurocognitive disorders.
関連する概念動画
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management
652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437


